Description
AZD-5363isanoralpan-AKTinhibitorthatcauseshyperphosphorylationofAKT,lockingitinacatalyticallyinactivestate,unabletophosphorylatedownstreamsignalingsubstratessuchasPRAS40andGSK-β.Thiscompounddisplaysanticancerchemotherapeuticactivity,inhibitingproliferationandinducingtumorregressionininvitroandinvivomodelsofHER2+breastcancerandprostatecancer.AZD-5363mayalsoexhibitinhibitoryactivityagainstRho-associatedproteinkinase(ROCK),p70S6K,PKA,MKK1,MSK1,MSK2,PKC,PKG,PRKX,andRSK2/3.
References
AddieM,BallardP,ButtarD,etal.Discoveryof4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide(AZD5363),anorallybioavailable,potentinhibitorofAktkinases.JMedChem.2013Mar14;56(5):2059-73.PMID:23394218.
LamoureuxF,ThomasC,CrafterC,etal.BlockedautophagyusinglysosomotropicagentssensitizesresistantprostatetumorcellstothenovelAktinhibitorAZD5363.ClinCancerRes.2013Feb15;19(4):833-44.PMID:23258740.
DaviesBR,GreenwoodH,DudleyP,etal.PreclinicalpharmacologyofAZD5363,aninhibitorofAKT:pharmacodynamics,antitumoractivity,andcorrelationofmonotherapyactivitywithgeneticbackground.MolCancerTher.2012Apr;11(4):873-87.PMID:22294718.